Karyopharm Therapeutics, Inc. (KPTI)

10.03 +0.36 (+3.72%) USD  |  NASDAQ  |  Feb 23, 16:00
10.04 +0.02 (+0.15%) After-Hours: 19:59
More

Karyopharm Therapeutics Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for KPTI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Alnylam Pharmaceuticals, Inc. Upgrade
Baxter International, Inc. Upgrade
Bruker Corp. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Agios Pharmaceuticals, Inc. Upgrade